International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
Year: 2021
Type: review
Abstract: Approximately 20% of patients diagnosed with a phaeochromocytoma or paraganglioma carry a germline mutation in one of the succinate dehydrogenase (SDHx) genes (SDHA, SDHB, SDHC and SDHD), which encode the four subunits of the SDH enzyme. When a pathogenic SDHx mutation is identified in an affected patient, genetic counselling is proposed for first-degree relatives. Optimal initial evaluation and follow-up of people who are asymptomatic but might carry SDHx mutations have not yet been agreed. Thus, we established an international consensus algorithm of clinical, biochemical and imaging screening at diagnosis and during surveillance for both adults and children. An international panel of 29 experts from 12 countries was assembled, and the Delphi method was used to reach a consensus on 41 statements. This Consensus Statement covers a range of topics, including age of first genetic testing, appropriate biochemical and imaging tests for initial tumour screening and follow-up, screening for rare SDHx-related tumours and management of elderly people who have an SDHx mutation. This Consensus Statement focuses on the management of asymptomatic SDHx mutation carriers and provides clinicians with much-needed guidance. The standardization of practice will enable prospective studies in the near future.
Source: Nature Reviews Endocrinology
Authors: Laurence Amar, Karel Pacak, Olivier Steichen, Scott A. Akker, Simon J. B. Aylwin, Eric Baudin, Alexandre Buffet, Nelly Burnichon, Roderick J. Clifton-Bligh, Patricia L. M. Dahia, Martin Fassnacht, Ashley B. Grossman, Philippe Herman, Rodney J. Hicks, Andrzej Januszewicz, Camilo Jimenez, Henricus P. M. Kunst, Dylan Lewis, Massimo Mannelli, Mitsuhide Naruse, Mercedes Robledo, David Taïeb, David R. Taylor, Henri J. L. M. Timmers, Giorgio Treglia, Nicola Tufton, William F. Young, Jacques W. M. Lenders, Anne-Paule Gimenez-Roqueplo, Charlotte Lussey-Lepoutre
Institutions: Inserm, La Ligue Contre le Cancer, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Sorbonne Université, Hôpital Tenon, St Bartholomew's Hospital, Barts Health NHS Trust, King's College Hospital NHS Foundation Trust, Institut Gustave Roussy, The University of Sydney, Royal North Shore Hospital, The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio, University of Würzburg, Universitätsklinikum Würzburg, Queen Mary University of London, The Royal Free Hospital, Churchill Hospital, Oxford Centre for Diabetes, Endocrinology and Metabolism, Université Paris Cité, Hôpital Lariboisière, The University of Melbourne, Peter MacCallum Cancer Centre, Institute of Cardiology, The University of Texas MD Anderson Cancer Center, Maastricht University Medical Centre, Radboud University Medical Center, University of Florence, Kyoto Medical Center, Ijinkai Takeda General Hospital, Spanish National Cancer Research Centre, Centre for Biomedical Network Research on Rare Diseases, Aix-Marseille Université, Hôpital de la Timone, Ente Ospedaliero Cantonale, Università della Svizzera italiana, University of Lausanne, Mayo Clinic, University Hospital Carl Gustav Carus, Technische Universität Dresden, Pitié-Salpêtrière Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W3162562470
